The United States has told South Africa it is starting to wind down PEPFAR support, a decision that could rattle HIV prevention and treatment services used by millions. Clinic managers and community groups warn a drawdown would trigger layoffs, slow testing and interrupt antiretroviral therapy in districts with some of the highest HIV burdens in the world. The move lands after more than a year of mounting diplomatic friction between Washington and Pretoria.
What Washington Just Put on the Table
According to The New York Times, the Trump administration plans to begin removing South Africa from the President’s Emergency Plan for AIDS Relief, or PEPFAR, and start a phased drawdown of U.S. programs in the country. A State Department official told South African counterparts the step followed what U.S. diplomats described as Pretoria’s failure to make “demonstrable progress” on a set of policy requests, and warned that funding could be terminated if those concerns are not addressed. Officials have cast the shift as part of a broader rethink of how Washington delivers global health aid.
Policy Demands Critics Say Have Little to Do With HIV
Reporting from Semafor says the administration linked the decision to a list of nonhealth demands, including changes to Black Economic Empowerment rules, limits on South Africa’s ties with Iran and land-expropriation measures. A Senate aide quoted by Semafor called those asks “political.” The outlet also reports U.S. officials intend to keep some health worker funding in place into 2027, while beginning to wind down program awards later this year. Advocates argue that tying life-saving support to unrelated diplomatic fights risks rolling back years of hard-won progress.
PEPFAR’s Footprint And Earlier Funding Shocks
PEPFAR has been the flagship U.S. HIV program for more than two decades and has long provided sustained treatment and prevention support in South Africa, according to KFF. South Africa’s Parliament was told in 2025 that earlier U.S. funding cuts, along with a pause in disbursements, had disrupted services in 27 high-burden districts and put thousands of jobs at risk, according to a parliamentary press release. While the national budget pays for most antiretroviral medicines, many community-level prevention, outreach and support services still depend heavily on donor grants.
What the Models Say Happens If the Money Stops
Modeling studies warn that a rapid or sustained withdrawal of PEPFAR-supported activities would lead to measurable increases in new HIV infections and AIDS-related deaths unless replacement funding and careful planning are in place. A multi-model analysis available via PMC estimates tens of thousands of additional deaths in the near term, with far larger impacts over the coming decades if coverage drops and is not restored. Public health experts say the human toll will hinge on how quickly Pretoria and other funders can plug gaps and manage a complex transition.
What Happens Next
Semafor reports that U.S. Ambassador Leo Brent Bozell III is expected to meet officials from South Africa’s Health Ministry to formally deliver the decision and talk through timelines for implementation. Governments and major international funders, including the Global Fund and private foundations, will now face pressure to design a phased handover that avoids sudden gaps in care. Analysts caution that solid planning and real money, not just warm statements, will be essential to keep clinics open and staff in place. The announcement deepens an already tense diplomatic rift and leaves urgent questions about who will pay for prevention, testing and treatment in the months ahead.
